Regulatory authorities approve JTA Phase III study in osteoarthritic knee pain and ALLOB Phase IIb study in difficult fractures Gosselies, Belgium, 23 March 2020, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company...
GENEVA–(BUSINESS WIRE)–Regulatory News: “We must put the fight against COVID-19 and the safety of MS patients first. Initiation of the trial will now take place once hospitals have more capacities for clinical research and are able to ensure that MS...
NEW YORK, March 19, 2020 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced positive feedback from its initial...
20-valent pneumococcal conjugate vaccine demonstrated comparable safety and immunogenicity profile to licensed pneumococcal vaccines March 18, 2020 04:15 PM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced top-line...
SOUTH SAN FRANCISCO, Calif., March 18, 2020 /PRNewswire/ — Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced proactive steps the Company is taking in support of public heath efforts to prevent furtherspread of coronavirus (or COVID-19) around the...
Email
Text